Group items tagged

The global preventable vaccine market is projected to grow at a CAGR of 8.99% over 2012 to 2016. One of the key factors contributing to this market's growth is the increase in demand for vaccination. Along with this, there has also been a marked increase in market consolidation. However, the emergence of regional players could prove to be one of the major challenges to market growth.

The tool on apoptosis in oncology also assists in analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future.

Analytical tools to analyses antibodies and peptides in oncology lead to analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug competitive landscape. A progress analysis on current and emerging drugs for cancer antibodies in oncology lays down a comprehensive framework for further analysis of the field.

An extensive research of the primary battery and cell markets in the world along with insights into the market size for primary batteries and cells indicate strong growth potentials and assists marketers in formulating strategic business decisions. Major product segments include air-zinc primary batteries and cells, lithium primary batteries and cells, manganese dioxide primary batteries and cells, mercuric oxide primary batteries and cells, silver oxide primary batteries and cells, parts of primary batteries and cells.